Men undergoing treatment for prostate cancer could be safely given far less radiotherapy, a major trial has found. Doses can be cut by three-quarters meaning five higher doses is enough, instead of the 20 or so given now. The international trial involved nearly 900 men with medium-risk prostat
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp